White paperThe Enterprise Framework for Compliant, Scalable AI
Download now

Smart Strategies for Life Sciences: Leveraging Data for APM Excellence

Watch this on-demand webinar with Blue Mountain and USDM to learn how life sciences teams connect asset, maintenance, and calibration data to improve uptime, defend compliance, and apply AI to asset performance management without losing GxP discipline.

Smart Strategies for Life Sciences: Leveraging Data for APM Excellence
Webinar

Watch this webinar

Watch this on-demand webinar with Blue Mountain and USDM to learn how life sciences teams connect asset, maintenance, and calibration data to improve uptime, defend compliance, and apply AI to asset performance management without losing GxP discipline.

Fill out the short form and scroll down to access the full content.

We only use your details to deliver this download and follow up on your request. No newsletter detour. Unsubscribe anytime.

Agree to Privacy Policy and Email Opt-In *

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.

Asset performance management only works when the data underneath it can be trusted.

Manufacturing, facilities, engineering, quality, and IT teams often manage asset, maintenance, and calibration data across disconnected systems. That fragmentation makes it harder to see equipment risk, coordinate work, defend compliance, and make timely decisions.

In this on-demand webinar, experts from Blue Mountain and USDM Life Sciences discuss how regulated organizations can strengthen their data strategy, improve asset performance management (APM), and use AI-enabled insights without losing GxP discipline. Watch the recording to see how connected asset data supports both reliability and inspection readiness.

What you will learn

  • Build a stronger asset data foundation: identify the equipment, maintenance, calibration, and operational data needed for better decisions.
  • Use APM to improve uptime: understand how connected asset management can reduce reactive work and support predictive maintenance.
  • Protect compliance visibility: connect operational improvements to audit trails, controlled workflows, data integrity, and inspection-ready evidence.
  • Apply AI where it matters: use analytics and intelligent workflows to prioritize risk, spot performance patterns, and support continuous improvement.

Why APM matters in regulated operations

Life sciences companies need equipment and facility operations that are efficient, compliant, and resilient. APM helps teams move from manual follow-up and siloed records toward a more connected operating model: assets are visible, maintenance is planned, calibration status is controlled, and teams can act before issues become deviations or downtime.

The opportunity is not just better maintenance. It is a cleaner digital thread across assets, data, decisions, and evidence.

USDM point of view Smart manufacturing in life sciences starts with governed operational data. AI and predictive maintenance are only useful when the underlying asset records, workflows, and compliance evidence are trustworthy. When validated systems hold regulated asset data, a continuous compliance approach keeps them inspection-ready as platforms evolve.

Key takeaways

  • Data strategy comes first. APM depends on accurate, connected, and usable asset data across maintenance, calibration, quality, and operations.
  • APM improves more than uptime. The right operating model can support cost control, resource planning, deviation prevention, and inspection readiness.
  • AI needs guardrails. Predictive insights should be tied to governed workflows, validated use cases where appropriate, AI governance, and clear human accountability.
  • Partner alignment matters. Blue Mountain provides life sciences asset and calibration capabilities; USDM helps align implementation, validation, data integrity, and change governance to regulated expectations.

KPIs to evaluate APM maturity

Program metrics to track
ReliabilityUnplanned downtimeTrack avoidable equipment downtime before and after predictive maintenance and APM workflow adoption.
ComplianceCalibration on-time rateMeasure whether critical assets stay within required calibration intervals and documented tolerances.
ExecutionWork order cycle timeMonitor how quickly maintenance and corrective actions move from issue identification to documented closure.
Data integrityComplete asset recordsAssess asset records with ownership, status, history, audit trail, and supporting evidence available.

Who should watch

  • Manufacturing, operations, and facilities leaders responsible for uptime, maintenance, and asset reliability.
  • Quality and compliance teams accountable for calibration records, audit trails, deviations, and inspection readiness.
  • IT, data, and automation leaders modernizing asset, maintenance, and operational systems.
  • Executives evaluating AI, smart factory, and connected operations initiatives in regulated environments.

FAQ: Data and APM in life sciences

What is asset performance management (APM) in a regulated environment?

APM is a connected operating model for managing equipment, maintenance, and calibration so assets stay visible, maintenance is planned, calibration status is controlled, and teams can act before issues become deviations or downtime. In life sciences, it also has to preserve audit trails, controlled workflows, and inspection-ready evidence.

Why is data strategy the starting point for APM?

APM depends on accurate, connected, and usable asset data across maintenance, calibration, quality, and operations. Without a trustworthy data foundation, predictive maintenance and AI insights can mislead rather than help. A stronger data foundation comes first, then the analytics and workflows built on top of it.

How does APM support compliance, not just uptime?

The right operating model ties operational improvements to audit trails, controlled workflows, data integrity, and documented evidence. That connects better maintenance and calibration execution directly to deviation prevention and inspection readiness.

How should AI and predictive maintenance be governed?

Predictive insights should be tied to governed workflows, validated use cases where appropriate, and clear human accountability. An AI governance approach keeps intelligent workflows trustworthy in GxP operations.

What roles do Blue Mountain and USDM play?

Blue Mountain provides life sciences asset and calibration capabilities, while USDM helps align implementation, validation, data integrity, and change governance to regulated expectations. Together that supports an APM program that improves reliability and holds up to inspection.

Watch the on-demand webinar

Watch the full recording with Blue Mountain and USDM Life Sciences to see how regulated organizations strengthen their data strategy, improve APM, and apply AI-enabled insights without losing GxP discipline. If your team is planning an APM or calibration modernization program, talk with USDM about validation, data integrity, workflow design, and governed adoption.

Keep going

For more context, explore USDM’s perspective on enterprise asset management in life sciences and the Blue Mountain partner page. To keep validated asset systems audit-ready as they change, see USDM Cloud Assurance.

Watch the webinar

Fill out the short form above to access the complete download.

Explore capabilities

Find the USDM practice area most relevant to this topic.

Platform partners

See how USDM delivers outcomes on the platforms you use.

Related resources

Keep exploring

Hand-picked blogs, case studies, and guides on the same topic.

White Paper

Anticipating Regulatory Compliance for Artificial Intelligence in Life Sciences

A practical white paper for Quality, Regulatory, IT, and Data leaders on governing, validating, and monitoring AI in GxP workflows ahead of FDA and global regulatory expectations.

Read
AI deploymentGovernance

Daily Monitoring Enables Immediate Action for Security Issues and Continuous Compliance

Clinical-stage pharmaceutical company running clinical trials under global regulatory oversight, using a Clinical Data Management System (CDMS) with admin-level / Vault Owner access controls.

Learn how using a CDMS audit trail supported daily security monitoring, helped detect critical issues, and enabled swift resolutions.

Detection-to-Action Window

Within 24 hours

See proof
White Paper

Using PTC's ThingWorx Solution in a GxP Regulated Environment

A practical guide to adopting PTC ThingWorx Industrial IoT in GxP regulated life sciences operations — using risk-based validation, data integrity controls, and lifecycle governance so connected manufacturing improves visibility without weakening compliance.

Read
AI deploymentGovernance

Intelligent Query Monitoring Helps Identify High- and Low-Performing Clinical Sites and Users

Clinical-stage pharmaceutical company running multi-year clinical trials on a Veeva Electronic Data Capture (EDC) platform across multiple clinical sites.

Explore ways to extract business insights from EDC metadata for query metrics, query causes, and query agents.

Review effort reduced

50-60%

See proof